US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

0.4170

-0.0355-7.85%

Post-market: 0.4150-0.0020-0.48%19:50 EDT

Volume:530.36K

Turnover:223.44K

Market Cap:16.94M

PE:-0.24

High:0.4563

Open:0.4563

Low:0.4022

Close:0.4525

52wk High:2.60

52wk Low:0.3720

Shares:40.63M

Float Shares:33.99M

Volume Ratio:1.53

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7229

EPS(LYR):2.69

ROE:-24.07%

ROA:-10.87%

PB:0.20

PE(LYR):0.16

Loading ...

Overview Company News Filings

Scienture Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview

Scienture Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview

Scienture Shares Surge 48% After Co Signs Deals to Expand Reach of Opioid Overdose Spray

THOMSON REUTERS

Why Is Scienture Holdings Stock (SCNX) Up Today?

Shares of Scienture up 60.1% Premarket After Co Signs Deals to Expand Reach of Opioid Overdose Spray

THOMSON REUTERS

Scienture signs GPO agreements for REZENOPY reaching over 5,000 U.S. institutions

SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions

Scienture Holdings Initiated at Buy by Maxim Group

Scienture initiated with a Buy at Maxim

BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney

BUZZ-Scienture jumps after expanding access to hypertension drug

Scienture Holdings Reaffirms Q1 2026 Growth Outlook

SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

BUZZ-Scienture Holdings jumps after U.S. FDA clears opioid overdose spray

Scienture Announces Issuance of Orange Book-Listable Patent Covering Rezenopy™, the Highest Dosage Naloxone Hcl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment

THOMSON REUTERS

EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment

Benzinga_recent_news

BRIEF-Scienture Provides Update On The Commercial Launch Of Rezenopy

Scienture Holdings Launches High-Strength REZENOPY Naloxone Nasal Spray in U.S. Market

Scienture Holdings Inc - Rezenopy Expected Commercially Available Early Q2 2026

THOMSON REUTERS

SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.417,"timestamp":1774641600000,"preClose":0.4525,"halted":0,"volume":530360,"hourTrading":{"tag":"盘后","latestPrice":0.415,"preClose":0.417,"latestTime":"19:50 EDT","volume":9323,"amount":3894.3171,"timestamp":1774655426160,"change":-0.002,"changeRate":-0.004796,"amplitude":0.0247},"delay":0,"changeRate":-0.07845303867403322,"floatShares":33992500,"shares":40630815,"eps":-1.7229,"marketStatus":"Market Closed","change":-0.0355,"latestTime":"03-27 16:00:00 EDT","open":0.4563,"high":0.4563,"low":0.4022,"amount":223438.46700600002,"amplitude":0.119558,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.7229,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.4525,"preHourTrading":{"tag":"盘前","latestPrice":0.4376,"preClose":0.4525,"latestTime":"09:23 EDT","volume":13391,"amount":5857.081857130001,"timestamp":1774617799595,"change":-0.0149,"changeRate":-0.032928,"amplitude":0.042873},"postHourTrading":{"tag":"盘后","latestPrice":0.415,"preClose":0.417,"latestTime":"19:50 EDT","volume":9323,"amount":3894.3171,"timestamp":1774655426160,"change":-0.002,"changeRate":-0.004796,"amplitude":0.0247},"volumeRatio":1.527047},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","floatShares":33992500,"roa":"-10.87%","roe":"-24.07%","lyrEps":2.685903,"volumeRatio":1.527047,"shares":40630815,"dividePrice":0,"high":0.4563,"amplitude":0.119558,"preClose":0.4525,"low":0.4022,"week52Low":0.372,"pbRate":"0.20","psRate":"25.93","week52High":2.6,"institutionHeld":0,"latestPrice":0.417,"eps":-1.7229,"divideRate":0,"volume":530360,"delay":0,"ttmEps":-1.7229,"open":0.4563,"prevYearClose":0.51,"prevWeekClose":0.48,"prevMonthClose":0.4301,"prevQuarterClose":0.51,"fiveDayClose":0.48,"twentyDayClose":0.4301,"sixtyDayClose":0.4951},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"SCNX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"SCNX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-05-12","symbol":"SCNX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-03-26","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"SCNX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-1.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNX\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-25","recordDate":"2024-03-18","paymentDate":"2024-03-22","value":8,"currency":"USD"},{"executeDate":"2024-07-19","recordDate":"2024-07-19","paymentDate":"2024-07-24","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1771992000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNX","date":"2026-03-26","current":-0.242034,"percent":0.408,"low":-4.335221,"twenty":-1.109941,"median":-0.835956,"eighty":1.312822,"high":3.580326,"avg":-0.186521,"sd":1.693138,"marketCap":18633291},"quantilePoints":[{"date":"2024-09-27","current":-0.598388,"twenty":-0.613397,"median":-0.60738,"eighty":-0.601331,"marketCap":10677383},{"date":"2024-10-04","current":-0.575439,"twenty":-0.613397,"median":-0.603293,"eighty":-0.596854,"marketCap":10267882},{"date":"2024-10-11","current":-0.569717,"twenty":-0.610449,"median":-0.596691,"eighty":-0.575112,"marketCap":10165786},{"date":"2024-10-18","current":-3.316594,"twenty":-3.320439,"median":-0.603293,"eighty":-0.579563,"marketCap":59179885},{"date":"2024-10-25","current":-3.532893,"twenty":-3.381003,"median":-0.61388,"eighty":-0.587997,"marketCap":63039443},{"date":"2024-10-31","current":-3.835472,"twenty":-3.470407,"median":-1.920019,"eighty":-0.593421,"marketCap":68438535},{"date":"2024-11-08","current":-3.92083,"twenty":-3.680939,"median":-3.316594,"eighty":-0.596527,"marketCap":69961625},{"date":"2024-11-15","current":3.401097,"twenty":-3.547313,"median":-1.920019,"eighty":-0.574948,"marketCap":68584767},{"date":"2024-11-22","current":3.456572,"twenty":-3.511744,"median":-0.611468,"eighty":3.395976,"marketCap":69703464},{"date":"2024-11-29","current":3.136519,"twenty":-3.477174,"median":-0.603293,"eighty":3.362691,"marketCap":63249440},{"date":"2024-12-06","current":3.110915,"twenty":-3.463831,"median":-0.596691,"eighty":3.285878,"marketCap":62733118},{"date":"2024-12-13","current":3.337086,"twenty":-3.450219,"median":-0.582313,"eighty":3.360949,"marketCap":67293962},{"date":"2024-12-20","current":3.469375,"twenty":-3.422821,"median":-0.572987,"eighty":3.384019,"marketCap":69961625},{"date":"2024-12-27","current":2.837803,"twenty":-3.405517,"median":1.134043,"eighty":3.366915,"marketCap":57225683},{"date":"2025-01-03","current":2.561875,"twenty":-3.372831,"median":2.613767,"eighty":3.343052,"marketCap":51661454},{"date":"2025-01-10","current":2.200068,"twenty":-3.341588,"median":2.571818,"eighty":3.331965,"marketCap":44365450},{"date":"2025-01-17","current":1.983099,"twenty":-3.320439,"median":2.304552,"eighty":3.323431,"marketCap":39990159},{"date":"2025-01-24","current":1.820372,"twenty":-3.285831,"median":2.061208,"eighty":3.308922,"marketCap":36708691},{"date":"2025-01-31","current":1.69236,"twenty":-3.231997,"median":1.995032,"eighty":3.279477,"marketCap":34127269},{"date":"2025-02-07","current":1.431997,"twenty":-2.180107,"median":1.896311,"eighty":3.250031,"marketCap":28876920},{"date":"2025-02-14","current":1.375585,"twenty":-0.618263,"median":1.823627,"eighty":3.227841,"marketCap":27739344},{"date":"2025-02-21","current":1.184652,"twenty":-0.615326,"median":1.76613,"eighty":3.213059,"marketCap":23889088},{"date":"2025-02-28","current":1.145598,"twenty":-0.611128,"median":1.69236,"eighty":3.194897,"marketCap":23101536},{"date":"2025-03-07","current":1.045792,"twenty":-0.608474,"median":1.646775,"eighty":3.193463,"marketCap":21088902},{"date":"2025-03-14","current":0.538084,"twenty":-0.602312,"median":1.540482,"eighty":3.184314,"marketCap":10850721},{"date":"2025-03-21","current":0.733356,"twenty":-0.598212,"median":1.425488,"eighty":3.168951,"marketCap":14788483},{"date":"2025-03-28","current":0.715999,"twenty":-0.597181,"median":1.375585,"eighty":3.16127,"marketCap":14438460},{"date":"2025-04-04","current":1.435684,"twenty":-0.595056,"median":1.425488,"eighty":3.153589,"marketCap":13015619},{"date":"2025-04-11","current":1.12784,"twenty":-0.589891,"median":1.375585,"eighty":3.136519,"marketCap":10224770},{"date":"2025-04-17","current":1.246836,"twenty":-0.582313,"median":1.328698,"eighty":3.136519,"marketCap":11303565},{"date":"2025-04-25","current":1.311304,"twenty":-0.575439,"median":1.30873,"eighty":3.110915,"marketCap":11888016},{"date":"2025-05-02","current":1.325247,"twenty":-0.574621,"median":1.311304,"eighty":3.085311,"marketCap":12014418},{"date":"2025-05-09","current":1.290735,"twenty":-0.571352,"median":1.304933,"eighty":2.846338,"marketCap":11701542},{"date":"2025-05-16","current":-0.774291,"twenty":-0.575439,"median":1.297499,"eighty":2.837803,"marketCap":11803474},{"date":"2025-05-23","current":-0.765773,"twenty":-0.597508,"median":1.28756,"eighty":2.645772,"marketCap":11673621},{"date":"2025-05-30","current":-0.779626,"twenty":-0.610109,"median":1.27693,"eighty":2.645772,"marketCap":11884796},{"date":"2025-06-06","current":-0.894836,"twenty":-0.730719,"median":1.246836,"eighty":2.594563,"marketCap":13641086},{"date":"2025-06-13","current":-0.959367,"twenty":-0.765773,"median":1.225767,"eighty":2.581761,"marketCap":14624818},{"date":"2025-06-20","current":-0.856031,"twenty":-0.771761,"median":1.212713,"eighty":2.569829,"marketCap":13049535},{"date":"2025-06-27","current":-0.841318,"twenty":-0.780624,"median":1.184652,"eighty":2.512356,"marketCap":12825244},{"date":"2025-07-03","current":-1.247608,"twenty":-0.792738,"median":1.179469,"eighty":2.409427,"marketCap":19018822},{"date":"2025-07-11","current":-1.411087,"twenty":-0.813268,"median":1.154073,"eighty":2.262758,"marketCap":21510943},{"date":"2025-07-18","current":-1.789672,"twenty":-0.855997,"median":1.145598,"eighty":2.175929,"marketCap":27282172},{"date":"2025-07-25","current":-1.746651,"twenty":-0.908602,"median":1.122616,"eighty":2.108316,"marketCap":26626350},{"date":"2025-08-01","current":-1.669213,"twenty":-0.977436,"median":1.076168,"eighty":2.04385,"marketCap":25445872},{"date":"2025-08-08","current":-2.380911,"twenty":-1.247608,"median":1.000228,"eighty":2.013475,"marketCap":36295155},{"date":"2025-08-15","current":-0.96959,"twenty":-1.381833,"median":0.872216,"eighty":1.999328,"marketCap":19518727},{"date":"2025-08-22","current":-0.980842,"twenty":-1.373229,"median":0.796277,"eighty":1.985962,"marketCap":19745239},{"date":"2025-08-29","current":-0.980746,"twenty":-1.319883,"median":0.733356,"eighty":1.970949,"marketCap":19743303},{"date":"2025-09-05","current":-0.893537,"twenty":-1.247608,"median":0.689962,"eighty":1.941441,"marketCap":17987698},{"date":"2025-09-12","current":-0.924958,"twenty":-1.220075,"median":0.629211,"eighty":1.895443,"marketCap":18620241},{"date":"2025-09-19","current":-0.916402,"twenty":-1.093717,"median":0.546763,"eighty":1.883542,"marketCap":18448004},{"date":"2025-09-26","current":-0.858058,"twenty":-1.027837,"median":-0.570534,"eighty":1.845235,"marketCap":17273474},{"date":"2025-10-03","current":-0.892899,"twenty":-1.021738,"median":-0.575439,"eighty":1.825579,"marketCap":17974872},{"date":"2025-10-10","current":-0.787446,"twenty":-1.012393,"median":-0.59383,"eighty":1.815599,"marketCap":15852002},{"date":"2025-10-17","current":-0.608083,"twenty":-1.007669,"median":-0.598388,"eighty":1.784356,"marketCap":12241257},{"date":"2025-10-24","current":-2.680141,"twenty":-1.007669,"median":-0.596691,"eighty":1.730959,"marketCap":53953668},{"date":"2025-10-31","current":-0.791363,"twenty":-1.019031,"median":-0.603293,"eighty":1.707894,"marketCap":15930858},{"date":"2025-11-07","current":-1.280832,"twenty":-1.093717,"median":-0.610618,"eighty":1.69236,"marketCap":25784310},{"date":"2025-11-14","current":-1.151144,"twenty":-1.207623,"median":-0.619577,"eighty":1.689756,"marketCap":23173577},{"date":"2025-11-21","current":-1.10301,"twenty":-1.174718,"median":-0.731804,"eighty":1.679333,"marketCap":22671994},{"date":"2025-11-28","current":-1.184253,"twenty":-1.184253,"median":-0.746883,"eighty":1.679299,"marketCap":24341921},{"date":"2025-12-05","current":-1.19809,"twenty":-1.186625,"median":-0.754071,"eighty":1.614251,"marketCap":24626336},{"date":"2025-12-12","current":-1.198288,"twenty":-1.205799,"median":-0.765773,"eighty":1.560053,"marketCap":24630400},{"date":"2025-12-19","current":-0.985197,"twenty":-1.202636,"median":-0.770075,"eighty":1.540482,"marketCap":20250398},{"date":"2025-12-26","current":-1.058534,"twenty":-1.199158,"median":-0.774377,"eighty":1.505767,"marketCap":21757801},{"date":"2026-01-02","current":-1.008127,"twenty":-1.198169,"median":-0.779626,"eighty":1.460246,"marketCap":20721715},{"date":"2026-01-09","current":-1.092533,"twenty":-1.19726,"median":-0.785773,"eighty":1.433472,"marketCap":22456651},{"date":"2026-01-16","current":-1.033232,"twenty":-1.190657,"median":-0.792532,"eighty":1.424186,"marketCap":21237727},{"date":"2026-01-23","current":-1.008127,"twenty":-1.185676,"median":-0.799919,"eighty":1.415507,"marketCap":20721715},{"date":"2026-01-30","current":-0.962267,"twenty":-1.184253,"median":-0.804018,"eighty":1.403888,"marketCap":19779080},{"date":"2026-02-06","current":-0.84999,"twenty":-1.182312,"median":-0.81198,"eighty":1.386796,"marketCap":17471250},{"date":"2026-02-13","current":-0.850978,"twenty":-1.176993,"median":-0.828904,"eighty":1.372015,"marketCap":17491565},{"date":"2026-02-20","current":-0.812432,"twenty":-1.169902,"median":-0.82127,"eighty":1.36651,"marketCap":16699264},{"date":"2026-02-27","current":-0.880826,"twenty":-1.155018,"median":-0.816538,"eighty":1.358466,"marketCap":18105091},{"date":"2026-03-06","current":-0.794641,"twenty":-1.149758,"median":-0.814485,"eighty":1.328008,"marketCap":16333587},{"date":"2026-03-13","current":-1.009116,"twenty":-1.140915,"median":-0.812432,"eighty":1.323164,"marketCap":20742031},{"date":"2026-03-20","current":-0.903756,"twenty":-1.124163,"median":-0.826728,"eighty":1.314432,"marketCap":18576408},{"date":"2026-03-26","current":-0.906524,"twenty":-1.109941,"median":-0.835956,"eighty":1.312822,"marketCap":18633291}],"updateTime":1774680497598},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622826859","title":"Scienture Holdings Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826859","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826859?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:49","pubTimestamp":1774612144,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of28cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson March 30 (estimated) for the period ending D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F0U6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2620738815","title":"Scienture Holdings Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620738815","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620738815?lang=en_us&edition=fundamental","pubTime":"2026-03-20 19:19","pubTimestamp":1774005545,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of28cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson March 24 (estimated) for the period ending D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4080WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2618928553","title":"Scienture Shares Surge 48% After Co Signs Deals to Expand Reach of Opioid Overdose Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928553?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:32","pubTimestamp":1773235940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ1C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2618940746","title":"Why Is Scienture Holdings Stock (SCNX) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940746?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:15","pubTimestamp":1773234915,"startTime":"0","endTime":"0","summary":"Scienture Holdings stock rallied after the company revealed new purchase order agreements.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-scienture-holdings-stock-scnx-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-scienture-holdings-stock-scnx-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2618594748","title":"Shares of Scienture up 60.1% Premarket After Co Signs Deals to Expand Reach of Opioid Overdose Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594748?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:52","pubTimestamp":1773233522,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ191:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2618944045","title":"Scienture signs GPO agreements for REZENOPY reaching over 5,000 U.S. institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2618944045","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618944045?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:05","pubTimestamp":1773230725,"startTime":"0","endTime":"0","summary":"Scienture said it formalized multiple Group Purchasing Organization agreements for REZENOPY  Nasal Spray 10 mg. The agreements provide access to more than 5,000 U.S. healthcare institutions, including hospitals, clinics and nursing homes. Scienture said the agreements represent potential penetration into about 60% of the U.S. institutional market. The company cited IQVIA data showing the U.S. naloxone market at USD 141 million in annual sales and 9.4 million prescription units.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL42sbzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU0980610538.SGD","LU2095319765.USD","LU0314104364.USD","LU0130518102.USD","BK4121","LU0130102774.USD","BK4588","LU1791710400.SGD","LU0648000940.SGD","LU1201861165.SGD","IQV","SG9999014005.SGD","SG9999014021.USD","LU0882574055.USD","LU1201861249.SGD","BK4167","BK4112","IE00B3QW5Z07.USD","LU1989764748.USD","SG9999014039.USD","LU2210150020.SGD","LU0477156797.USD","LU2210149790.SGD","LU0648001328.SGD","IE00BGHQF748.EUR","BK4530","LU0477156953.USD","LU1791710582.SGD","NDAQ","BK4585","LU1261432733.SGD","LU1989764664.SGD","SCNX","LU0130517989.USD","SG9999014013.SGD","IE00B64PRP62.GBP","LU0198837287.USD","LU0528227936.USD","LU0130103400.USD"],"gpt_icon":0},{"id":"2618594296","title":"SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594296","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594296?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:05","pubTimestamp":1773230700,"startTime":"0","endTime":"0","summary":"Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253734/0/en/SCIENTURE-Broadens-Commercial-Access-for-REZENOPY-Highest-Dose-FDA-Approved-Naloxone-Nasal-Spray-Through-GPO-Agreements-Reaching-Over-5-000-U-S-Institutions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SCNX","BK4588","BK4167","LABU"],"gpt_icon":0},{"id":"2614741693","title":"Scienture Holdings Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2614741693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614741693?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:50","pubTimestamp":1771955400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SCNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 12:50 ET (17:50 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2613712681","title":"Scienture initiated with a Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2613712681","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613712681?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:33","pubTimestamp":1771940002,"startTime":"0","endTime":"0","summary":"Maxim initiated coverage of Scienture (SCNX) with a Buy rating and $1.50 price target Published first on TheFly – the ultimate source for real-time...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-initiated-with-a-buy-at-maxim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-initiated-with-a-buy-at-maxim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2608787246","title":"BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2608787246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608787246?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:17","pubTimestamp":1770128229,"startTime":"0","endTime":"0","summary":"** Palantir Technologies Inc PLTR.O:BUZZ - Jumps as US government contracts boost quarterly sales nL4N3YZ0PE** Merck & Co Inc MRK.N:BUZZ - Falls on downbeat 2026 profit and sales forecasts nL4N3YZ0U8     ** Newmont Corp NEM.N:     ** Gold Fields Ltd GFI.N:** AngloGold Ashanti PLC AU.N: ** Harmony Gold Mining Co Ltd HMY.N:BUZZ - Gold, silver miners gain as metal prices edge higher after two-session rout nL4N3YZ0ST** McDonald's Corp MCD.N:BUZZ - Up after brokerage BTIG upgrades to 'buy'  nL6N3YY0WK** SoFi Technologies Inc SOFI.O:BUZZ - Rises after J.P. Morgan upgrades to 'overweight' nL6N3YZ0MY     ** Rio Tinto PLC RIO.N:              ** BHP Group Ltd BHP.N:** Southern Copper Corp SCCO.N: ** Freeport-McMoRan Inc FCX.N:BUZZ - Copper miners rise on China stockpiling, stronger risk sentiment nL4N3YZ0W3** PepsiCo Inc PEP.O:BUZZ - Falls after reaffirming annual earnings forecast despite Q4 revenue beat nL4N3YZ0YH** FedEx Corp FDX.N:BUZZ - Gains after Bernstein upgrades rating to 'outperform' ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL6N3YZ0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLTA","SOFX","SOC","BK4559","NEM","ETN","MPC","BHP.AU","OVV","PLTY","JBLU","PLTZ","DVA","PLT","PLYY","EVR","ADM","RIO.AU","RARE","FDX","LU1223082196.USD","LU1162221912.USD","WST","IVVD","AU","PYPY","PEP","PLTG","PLOO","PLTW","RIO.UK","SCNX","DIS","HPQ","PYPG","GTBP","PLTD","BALL","MRK","PTIR","VSEC","PLTU","LU1066051225.USD","MCD"],"gpt_icon":1},{"id":"2608879095","title":"BUZZ-Scienture jumps after expanding access to hypertension drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879095","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879095?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:17","pubTimestamp":1770124624,"startTime":"0","endTime":"0","summary":"BUZZ-Scienture jumps after expanding access to hypertension drug** Shares of drugmaker Scienture Holdings SCNX.O rise 10.34% to $0.4993 premarket** Co says it has expanded access to Arbli, its ready-to-use liquid losartan for high blood pressure** Losartan treats hypertension, a condition where consistently high blood pressure increases the risk of stroke and heart disease - SCNX** Co says Arbli now available at more than 2,500 healthcare sites, with coverage for 100 million insured Americans** Expects continued Arbli prescription growth in Q1 and wider insurance and pharmacy coverage** Says its nasal spray for opioid overdose emergencies, Rezenopy, is set for a U.S. launch in Q2 2026 ** Shares fell ~92% in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4N3YZ1A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2608791448","title":"Scienture Holdings Reaffirms Q1 2026 Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2608791448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608791448?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123916,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc. outlined its outlook for the first quarter of 2026, expecting continued sequential growth in prescription volumes and adoption of ARBLI, its FDA-approved oral suspension of losartan potassium. The company anticipates improved commercial efficiency as initial launch investments begin generating recurring demand. Scienture also projects further expansion of payer and pharmacy engagement, which is expected to broaden patient access across both commercial and government sectors. The company reported a significant strengthening of its balance sheet in the last quarter, including a substantial reduction in outstanding debt and an increase in its cash position to approximately $7.0 million as of December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLc0zmbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4167","IE00B64PRP62.GBP","SG9999014013.SGD","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","BK4588","BK4112","SG9999014039.USD","IE00BKPKM429.USD","SCNX","BK4585","NDAQ"],"gpt_icon":0},{"id":"2608871631","title":"SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871631","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608871631?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123900,"startTime":"0","endTime":"0","summary":"Company highlights accelerating access and revenue growth for ARBLI and confirms REZENOPY launch timeline, addressing a combined US annual losartan and naloxone market size of close to $385 million Ou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/03/3231048/0/en/SCIENTURE-Provides-Commercial-Update-on-ARBLI-the-First-FDA-Approved-Ready-to-Use-Oral-Suspension-of-Losartan-Potassium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX","ARB"],"gpt_icon":0},{"id":"2603619598","title":"BUZZ-Scienture Holdings jumps after U.S. FDA clears opioid overdose spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2603619598","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603619598?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:25","pubTimestamp":1768397155,"startTime":"0","endTime":"0","summary":"BUZZ-Scienture Holdings jumps after U.S. FDA clears opioid overdose spray** Shares of specialty pharma firm Scienture Holdings SCNX.O rise 19.99% to $0.6472 premarket** Co says U.S. FDA has approved a new high-dose nasal spray, Rezenopy, for treating opioid overdoses** Says spray delivers 10mg naloxone to reverse overdoses from powerful opioids including fentanyl** Adds SCNX holds exclusive U.S. sales rights; Summit Biosciences will manufacture the product** Patent protection runs through February 2041; naloxone market worth $154 million, with 9.3 million units sold annually - IQVIA data** As of last close, stock down ~92% over the past year","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL4N3YF19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU0882574055.USD","BK4530","LU0528227936.USD","LU1791710582.SGD","LU0477156953.USD","LU0648000940.SGD","BK4588","LU0648001328.SGD","LU1989764664.SGD","LU1261432733.SGD","BK4121","LU0130102774.USD","LU1201861165.SGD","LU0980610538.SGD","BK4167","LU0130518102.USD","LU0198837287.USD","SCNX","LU1201861249.SGD","BK4585","LU0130103400.USD","LU1791710400.SGD","IQV","LU1989764748.USD","LU0477156797.USD"],"gpt_icon":0},{"id":"2603616116","title":"Scienture Announces Issuance of Orange Book-Listable Patent Covering Rezenopy™, the Highest Dosage Naloxone Hcl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616116?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:05","pubTimestamp":1768395900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nTUA3JWGMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2603616558","title":"EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616558","media":"Benzinga_recent_news","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616558?lang=en_us&edition=fundamental","pubTime":"2026-01-14 20:51","pubTimestamp":1768395060,"startTime":"0","endTime":"0","summary":"New US patent strengthens protection for Rezenopy, the FDA-approved 10 mg naloxone nasal spray.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/14/Naloxone-And-Narcan-Nasal-Spray-In-The-E.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/14/Naloxone-And-Narcan-Nasal-Spray-In-The-E.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49901588/exclusive-penny-stock-scientures-partner-secures-us-patent-for-highest-dosage-naloxone-spray-for-emergency-opioid-overdose-treatment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49901588/exclusive-penny-stock-scientures-partner-secures-us-patent-for-highest-dosage-naloxone-spray-for-emergency-opioid-overdose-treatment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2593348026","title":"BRIEF-Scienture Provides Update On The Commercial Launch Of Rezenopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348026?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:22","pubTimestamp":1766409727,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Provides Update On The Commercial Launch Of RezenopyDec 22 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE PROVIDES UPDATE ON THE COMMERCIAL LAUNCH OF REZENOPY, THE HIGHEST STRENGT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA1DGPVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2593803154","title":"Scienture Holdings Launches High-Strength REZENOPY Naloxone Nasal Spray in U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2593803154","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593803154?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408730,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc. has announced an update on the commercial launch of REZENOPY, a high-strength 10 mg naloxone HCl nasal spray, following its FDA approval in April 2024. Through an exclusive agreement with Summit Biosciences Inc., Scienture will oversee the U.S. commercialization of REZENOPY. The company plans to load the product into wholesale channels in the first quarter of 2026, with commercial availability expected in early Q2 2026. This initiative marks a significant expansion in Scienture’s product portfolio, aiming to address the growing need for effective opioid overdose treatments in the U.S. market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLbp8Fnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SG9999014005.SGD","LU2210150020.SGD","SG9999014013.SGD","BK4167","BK4585","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","SCNX","SG9999014039.USD","IE00BKPKM429.USD","BK4112","SG9999014021.USD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2593906480","title":"Scienture Holdings Inc - Rezenopy Expected Commercially Available Early Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593906480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593906480?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA1DGPVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2593480575","title":"SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2593480575","media":"GlobeNewswire","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593480575?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408700,"startTime":"0","endTime":"0","summary":"U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Dec.  22, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for exist","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/22/3209189/0/en/SCIENTURE-Provides-Update-on-the-Commercial-Launch-of-REZENOPY-the-Highest-Strength-Naloxone-HCl-Life-Saving-Opioid-Overdose-Emergency-Treatment-Approved-by-the-FDA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}